The benefits, costs and feasibility of a low incidence COVID-19 strategy

Czypionka, ThomasORCID: https://orcid.org/0000-0002-3381-1075; Iftekhar, Emil N.; Prainsack, Barbara; Priesemann, Viola; Bauer, Simon; Calero Valdez, André; Cuschieri, Sarah; Glaab, Enrico; Grill, Eva; Krutzinna, Jenny; Lionis, Christos; Machado, Helena; Martins, Carlos; Pavlakis, George N.; Perc, Matjaž; Petelos, Elena; Pickersgill, Martyn; Skupin, Alexander; Schernhammer, Eva; Szczurek, Ewa; Tsiodras, Sotirios; Willeit, Peter and Wilmes, Paul (2022) The benefits, costs and feasibility of a low incidence COVID-19 strategy. The Lancet Regional Health - Europe, 13, article 100294. https://doi.org/10.1016/j.lanepe.2021.100294

[img]
Preview
Text
czypionka-et-al-2022-benefits-feasibility-covid-19-strategy.pdf - Published Version
Available under License Creative Commons Attribution.

Download (456kB) | Preview
Item Type: Article in Academic Journal
Research Units: Current Research Groups > Health Economics and Health Policy
Date Deposited: 11 Jan 2022 07:56
Last Modified: 11 Jan 2022 07:57
DOI: 10.1016/j.lanepe.2021.100294
ISSN: 26667762
URI: https://irihs.ihs.ac.at/id/eprint/6023

Actions (login required)

View Item View Item